CA2078901A1 - Method for treating hypertension - Google Patents

Method for treating hypertension

Info

Publication number
CA2078901A1
CA2078901A1 CA002078901A CA2078901A CA2078901A1 CA 2078901 A1 CA2078901 A1 CA 2078901A1 CA 002078901 A CA002078901 A CA 002078901A CA 2078901 A CA2078901 A CA 2078901A CA 2078901 A1 CA2078901 A1 CA 2078901A1
Authority
CA
Canada
Prior art keywords
hypertension
compound
composition according
formula
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002078901A
Other languages
English (en)
French (fr)
Inventor
Eric Robert Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2078901A1 publication Critical patent/CA2078901A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Removal Of Specific Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002078901A 1991-09-25 1992-09-23 Method for treating hypertension Abandoned CA2078901A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US765,643 1991-09-25
US07/765,643 US5175179A (en) 1991-09-25 1991-09-25 Method for treating hypertension

Publications (1)

Publication Number Publication Date
CA2078901A1 true CA2078901A1 (en) 1993-03-26

Family

ID=25074097

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002078901A Abandoned CA2078901A1 (en) 1991-09-25 1992-09-23 Method for treating hypertension

Country Status (17)

Country Link
US (1) US5175179A (2)
EP (1) EP0534655B1 (2)
JP (1) JPH05194220A (2)
KR (1) KR950013756B1 (2)
AT (1) ATE124259T1 (2)
AU (1) AU644545B2 (2)
CA (1) CA2078901A1 (2)
DE (1) DE69203194T2 (2)
DK (1) DK0534655T3 (2)
ES (1) ES2073871T3 (2)
HU (1) HUT65276A (2)
IL (1) IL103202A0 (2)
MX (1) MX9205408A (2)
MY (1) MY129918A (2)
NZ (1) NZ244474A (2)
TW (1) TW209167B (2)
ZA (1) ZA927307B (2)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
AU2005276624B2 (en) * 2004-08-25 2011-09-29 Actelion Pharmaceuticals Ltd. Bicyclononene derivatives as renin inhibitors
US7799805B2 (en) * 2005-05-27 2010-09-21 Actelion Pharmaceuticals Ltd. Piperidine carboxylic acid amide derivatives
CL2007000595A1 (es) * 2006-03-08 2008-01-04 Actelion Pharmaceuticals Ltd Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
JP2826379B2 (ja) * 1990-01-22 1998-11-18 三共株式会社 チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
DK0514452T4 (da) * 1990-02-09 2000-09-18 Upjohn Co Anvendelse af insulin-sensibiliserende midler til behandling af hypertension

Also Published As

Publication number Publication date
DE69203194D1 (de) 1995-08-03
HU9203052D0 (en) 1992-12-28
HUT65276A (en) 1994-05-02
MY129918A (en) 2007-05-31
DE69203194T2 (de) 1995-11-02
US5175179A (en) 1992-12-29
JPH05194220A (ja) 1993-08-03
ES2073871T3 (es) 1995-08-16
AU644545B2 (en) 1993-12-09
TW209167B (2) 1993-07-11
KR950013756B1 (ko) 1995-11-15
NZ244474A (en) 1994-01-26
MX9205408A (es) 1993-03-01
IL103202A0 (en) 1993-02-21
EP0534655B1 (en) 1995-06-28
ATE124259T1 (de) 1995-07-15
KR930005621A (ko) 1993-04-20
DK0534655T3 (da) 1995-08-28
AU2532692A (en) 1993-04-22
ZA927307B (en) 1994-03-24
EP0534655A1 (en) 1993-03-31

Similar Documents

Publication Publication Date Title
JP3043430B2 (ja) ２−アルキルピロリジン類
US6329408B1 (en) Hypoglycemic thiazolidinediones and intermediates
HK64089A (en) Medicinal compositions comprising as an active ingredient substituted 1,4-benzoquinones
JPH04210683A (ja) チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
FR2516083A1 (fr) Derives de l'ergoline, procede pour leur preparation et medicaments les contenant
KR840001553B1 (ko) 시클로헥센 유도체의 제조방법
US5175179A (en) Method for treating hypertension
EP0097453A2 (en) Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
CA1313139C (en) D1-5-[(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl] thiazolidine-2,4-dione as an anti-atherosclerosis agent
HU199845B (en) Process for producing new spiro/chroman-4,4'-imidazolidine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
CA1050996A (en) Antidiabetic agent, "isoxazole derivatives"
JP2687398B2 (ja) アルドースリダクターゼ阻害剤
US4482568A (en) Inhibition of alcohol metabolism by tetramethylene sulfoxides
US20060241163A1 (en) Optically active (S)-hydantoin derivative
GB2378652A (en) Steroidal medicament for the treatment of diabetes
CH681983A5 (2)
CH647503A5 (fr) Derives de la 16-methoxy-16-methyl-prostaglandine e(1), procede pour leur synthese et medicaments gastro-protecteurs contenant lesdits derives.
US20060241162A1 (en) Optically active (R)-hydantoin derivative
GB2202849A (en) Substituted 1,3-dioxolane and 1,3-dioxane derivatives, processes for the production and their use
LU82829A1 (fr) Nouveaux derives de 16-methoxy-16-methyl-prostaglandine e1,leur procede de preparation et leur utilisation comme agents gastroprotecteurs
FR2845383A1 (fr) Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued